Analystreport

CytomX Therapeutics, Inc. (NASDAQ: CTMX) had its price target raised by analysts at Nomura to $44.00. They now have a "buy" rating on the stock.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com